Randomized controlled clinical study to evaluate the efficacy of Durvadi Lepa in Pama w.s.r. to Scabies in children.

Randomized controlled clinical study to evaluate the efficacy of Durvadi Lepa in Pama w.s.r. to Scabies in children. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075948

Enrollment

Registered

2024-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: children diagnosed as the case of pama children having pama without secondary infection

Exclusion criteria

Exclusion criteria: patients suffering from any other systemic disorder congenital anomalies immune deficiency disorder and inborn errors of metabolism kustha other than pama pama with secondary infection

Design outcomes

Secondary

Measure	Time frame
pitika varna , daha at day 1st,7th,14thTimepoint: Baseline 1st,7th ,14th	—

Primary

Measure	Time frame
kandu,toda at day 1st,7th,14Timepoint: Baseline 1st,7th ,14th	—

Countries

India

Contacts

Public ContactKS Ratanparkhi

CSMSS AYURVED MAHAVIDYALAYA AURANGABAD

karunaratnaparkhi@gmail.com9421771722

Outcome results